In line with the aforementioned data, the influence of SIRT2 on the Overall Survival (OS) may only exist in AKR1C1-highly-expressed (AKR1C1high) NSCLC patients, as indicated by the prolonged OS in SIRT2high sub-population (Figure 7A). Here, AKR1C1 is linked to non-small cell lung carcinoma.